{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:18:04Z","timestamp":1784092684493,"version":"3.55.0"},"reference-count":150,"publisher":"AIP Publishing","issue":"4","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA205348"],"award-info":[{"award-number":["R01CA205348"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA269897"],"award-info":[{"award-number":["R01CA269897"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM135009"],"award-info":[{"award-number":["P20GM135009"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008569","name":"Oklahoma Center for the Advancement of Science and Technology","doi-asserted-by":"publisher","award":["HF20-019"],"award-info":[{"award-number":["HF20-019"]}],"id":[{"id":"10.13039\/100008569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008569","name":"Oklahoma Center for the Advancement of Science and Technology","doi-asserted-by":"publisher","award":["HR23-069"],"award-info":[{"award-number":["HR23-069"]}],"id":[{"id":"10.13039\/100008569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["pubs.aip.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:p>Cancer therapies have evolved considerably over the past several decades. Physical interactions, particularly through phototherapy as a new class of treatment modality, have become widely used. Phototherapy utilizes light to combat cancer by generating heat (photothermal therapy), reactive oxygen species (photodynamic therapy), or photochemical internalization, to kill targeted cells. While these therapies have shown promise in pre-clinical studies, they have demonstrated limitations in clinical cancer treatment. Primarily, while phototherapies excel in eliminating primary tumors, they often fail to provide systemic effects, particularly when treating metastatic cancers, in addition to certain undesirable side effects. Phototherapy has been combined with immunotherapy, nanomedicine, and other cancer therapies to overcome specific weaknesses and enhance the therapeutic benefits of individual treatments. These combinations often involve nanomaterials to deliver adjuncts for phototherapy to the tumor site, immune stimulants\/adjuvants to enhance the immune response, and immune checkpoint inhibitors to counter immune suppression. Phototherapies may also be combined with specific photonics-related principles to enable simultaneous diagnostic and therapeutic effects, known as theranostics. Herein, we review current approaches to modern cancer therapies, such as nanotechnology-based therapies, immunotherapies, and especially phototherapy, and the combination of these therapies with diagnostic techniques in combating cancer.<\/jats:p>","DOI":"10.1063\/5.0252574","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:59:38Z","timestamp":1761749978000},"update-policy":"https:\/\/doi.org\/10.1063\/aip-crossmark-policy-page","source":"Crossref","is-referenced-by-count":2,"title":["Synergy between photonics and biological approaches\u2014A review of combination therapies for cancer theranostics"],"prefix":"10.1063","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6277-5159","authenticated-orcid":false,"given":"Jacob P.","family":"Adams","sequence":"first","affiliation":[{"name":"Stephenson School of Biomedical Engineering, The University of Oklahoma 1 , Norman, Oklahoma 73019,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5541-9417","authenticated-orcid":false,"given":"Luke","family":"Pauli","sequence":"additional","affiliation":[{"name":"Stephenson School of Biomedical Engineering, The University of Oklahoma 1 , Norman, Oklahoma 73019,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4636-8225","authenticated-orcid":false,"given":"Lin","family":"Wang","sequence":"additional","affiliation":[{"name":"Stephenson School of Biomedical Engineering, The University of Oklahoma 1 , Norman, Oklahoma 73019,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha","family":"Valerio","sequence":"additional","affiliation":[{"name":"Stephenson School of Biomedical Engineering, The University of Oklahoma 1 , Norman, Oklahoma 73019,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8822-3887","authenticated-orcid":false,"given":"Coline","family":"Furrer","sequence":"additional","affiliation":[{"name":"Stephenson School of Biomedical Engineering, The University of Oklahoma 1 , Norman, Oklahoma 73019,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3971-9130","authenticated-orcid":false,"given":"Min","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Oklahoma Health Sciences Center 2 , Oklahoma City, Oklahoma 73104,","place":["USA"]},{"name":"Department of Surgery, The University of Oklahoma Health Sciences Center 3 , Oklahoma City, Oklahoma 73104,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5790-4954","authenticated-orcid":false,"given":"Naoko","family":"Takebe","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Oklahoma Health Sciences Center 2 , Oklahoma City, Oklahoma 73104,","place":["USA"]},{"name":"Stephenson Cancer Center, The University of Oklahoma Health Sciences Center 4 , Oklahoma City, Oklahoma 73104,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1516-3841","authenticated-orcid":false,"given":"Joanne","family":"Tuohy","sequence":"additional","affiliation":[{"name":"VA-MD College of Veterinary Medicine, Virginia Tech 5 , Blacksburg, Virginia 24061,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7133-5794","authenticated-orcid":false,"given":"Wei R.","family":"Chen","sequence":"additional","affiliation":[{"name":"Stephenson School of Biomedical Engineering, The University of Oklahoma 1 , Norman, Oklahoma 73019,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"317","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"2025102910593259700_c1","volume-title":"Global Health Estimates 2020: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2019","author":"WHO","year":"2020"},{"issue":"2","key":"2025102910593259700_c2","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.eururo.2014.07.020","article-title":"Impact of the site of metastases on survival in patients with metastatic prostate cancer","volume":"68","year":"2015","journal-title":"Eur. Urol."},{"issue":"1","key":"2025102910593259700_c3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41416-020-01161-4","article-title":"The lingering mysteries of metastatic recurrence in breast cancer","volume":"124","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"3","key":"2025102910593259700_c4","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3390\/cancers6031769","article-title":"Drug resistance in cancer: An overview","volume":"6","year":"2014","journal-title":"Cancers"},{"issue":"7782","key":"2025102910593259700_c5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","year":"2019","journal-title":"Nature"},{"issue":"1","key":"2025102910593259700_c6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrc.2016.108","article-title":"Cancer nanomedicine: Progress, challenges and opportunities","volume":"17","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"2025102910593259700_c7","doi-asserted-by":"publisher","first-page":"109821","DOI":"10.1016\/j.biopha.2020.109821","article-title":"Cancer immunotherapy: Pros, cons and beyond","volume":"124","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"2025102910593259700_c8","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/intimm\/dxw030","article-title":"Cancer-induced heterogeneous immunosuppressive tumor microenvironments and their personalized modulation","volume":"28","year":"2016","journal-title":"Int. Immunol."},{"key":"2025102910593259700_c9","volume-title":"Science and Civilisation in China","year":"1983"},{"issue":"17","key":"2025102910593259700_c10","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.3390\/cancers13174447","article-title":"Photodynamic therapy: A compendium of latest reviews","volume":"13","year":"2021","journal-title":"Cancers"},{"issue":"8","key":"2025102910593259700_c11","first-page":"2628","article-title":"Photoradiation therapy for the treatment of malignant tumors","volume":"38","year":"1978","journal-title":"Cancer Res."},{"issue":"1","key":"2025102910593259700_c12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mla.2005.02.001","article-title":"Photodynamic therapy","volume":"20","year":"2005","journal-title":"Med. Laser Appl."},{"issue":"6","key":"2025102910593259700_c13","doi-asserted-by":"publisher","first-page":"762","DOI":"10.7150\/thno.14988","article-title":"Current approaches of photothermal therapy in treating cancer metastasis with nanotherapeutics","volume":"6","year":"2016","journal-title":"Theranostics"},{"key":"2025102910593259700_c14","doi-asserted-by":"publisher","first-page":"362","DOI":"10.2174\/138920107783018354","article-title":"Photochemical internalization: A new tool for drug delivery","volume":"8","year":"2007","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"2\u20133","key":"2025102910593259700_c15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S1011-1344(00)00082-8","article-title":"Measurement of the penetration depths of red and near infrared light in human \u201cex vivo\u201d tissues","volume":"57","year":"2000","journal-title":"J. Photochem. Photobiol. B"},{"key":"2025102910593259700_c16","doi-asserted-by":"publisher","first-page":"691697","DOI":"10.3389\/fchem.2021.691697","article-title":"Photodynamic therapy\u2014current limitations and novel approaches","volume":"9","year":"2021","journal-title":"Front. Chem."},{"key":"2025102910593259700_c17","doi-asserted-by":"publisher","first-page":"e00747","DOI":"10.7554\/eLife.00747","article-title":"Evolutionary dynamics of cancer in response to targeted combination therapy","volume":"2","year":"2013","journal-title":"eLife"},{"issue":"23","key":"2025102910593259700_c18","doi-asserted-by":"publisher","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"2025102910593259700_c19","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/S1470-2045(00)00166-2","article-title":"Photodynamic therapy: A clinical reality in the treatment of cancer","volume":"1","year":"2000","journal-title":"Lancet Oncol."},{"issue":"8","key":"2025102910593259700_c20","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1007\/s10103-018-2534-5","article-title":"Enhancing the effects of chemotherapy by combined macrophage-mediated photothermal therapy (PTT) and photochemical internalization (PCI)","volume":"33","year":"2018","journal-title":"Lasers Med. Sci."},{"issue":"1","key":"2025102910593259700_c21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3390\/cancers12010165","article-title":"Photochemical internalization: Light paves way for new cancer chemotherapies and vaccines","volume":"12","year":"2020","journal-title":"Cancers"},{"issue":"8","key":"2025102910593259700_c22","doi-asserted-by":"publisher","first-page":"8633","DOI":"10.1021\/acsnano.8b04371","article-title":"Bioinspired hybrid protein oxygen nanocarrier amplified photodynamic therapy for eliciting anti-tumor immunity and abscopal effect","volume":"12","year":"2018","journal-title":"ACS Nano"},{"issue":"1","key":"2025102910593259700_c23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0304-3835(97)04707-1","article-title":"Laser-photosensitizer assisted immunotherapy: A novel modality for cancer treatment","volume":"115","year":"1997","journal-title":"Cancer Lett."},{"key":"2025102910593259700_c24","doi-asserted-by":"publisher","first-page":"112355","DOI":"10.1016\/j.jphotobiol.2021.112355","article-title":"Light-controlled elimination of PD-L1+ cells","volume":"225","year":"2021","journal-title":"J. Photochem. Photobiol. B"},{"issue":"2","key":"2025102910593259700_c25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/1948-5956.100000e2","article-title":"History of cancer, ancient and modern treatment methods","volume":"1","year":"2009","journal-title":"J. Canc. Sci. Ther."},{"issue":"1","key":"2025102910593259700_c26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.5306\/wjco.v7.i1.54","article-title":"Historical review of the causes of cancer","volume":"7","year":"2016","journal-title":"World J. Clin. Oncol."},{"key":"2025102910593259700_c27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.reth.2021.02.006","article-title":"Immune evasion by cancer stem cells","volume":"17","year":"2021","journal-title":"Regener. Ther."},{"key":"2025102910593259700_c28","first-page":"S185","article-title":"Immune evasion in cancer: Mechanistic basis and therapeutic strategies","volume-title":"Seminars in cancer biology","year":"2015"},{"key":"2025102910593259700_c29","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2165\/00063030-200519060-00002","article-title":"Strategies of tumor immune evasion","volume":"19","year":"2005","journal-title":"BioDrugs"},{"issue":"6","key":"2025102910593259700_c30","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/joim.12470","article-title":"The immune system and cancer evasion strategies: Therapeutic concepts","volume":"279","year":"2016","journal-title":"J. Intern. Med."},{"issue":"21","key":"2025102910593259700_c31","doi-asserted-by":"publisher","first-page":"8643","DOI":"10.1158\/0008-5472.CAN-07-6611","article-title":"A history of cancer chemotherapy","volume":"68","year":"2008","journal-title":"Cancer Res."},{"key":"2025102910593259700_c32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ejpb.2015.03.018","article-title":"Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy","volume":"93","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"2025102910593259700_c33","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jconrel.2014.12.030","article-title":"Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications","volume":"200","year":"2015","journal-title":"J. Controlled Release"},{"issue":"10018","key":"2025102910593259700_c34","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0140-6736(15)00986-1","article-title":"Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): A global, randomised, open-label, phase 3 trial","volume":"387","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"2025102910593259700_c35","doi-asserted-by":"publisher","first-page":"2330007","DOI":"10.1142\/S1793545823300070","article-title":"Immune modulations of the tumor microenvironment in response to phototherapy","volume":"16","year":"2023","journal-title":"J. Innov. Opt. Health Sci."},{"issue":"11","key":"2025102910593259700_c36","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s41565-019-0567-y","article-title":"Smart cancer nanomedicine","volume":"14","year":"2019","journal-title":"Nat. Nanotechnol."},{"issue":"6","key":"2025102910593259700_c37","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"2025102910593259700_c38","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.imlet.2018.01.011","article-title":"Therapeutic cancer vaccines: From initial findings to prospects","volume":"196","year":"2018","journal-title":"Immunol. Lett."},{"issue":"4","key":"2025102910593259700_c39","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/iub.2180","article-title":"Cell transfer-based immunotherapies in cancer: A review","volume":"72","year":"2020","journal-title":"IUBMB Life"},{"issue":"6230","key":"2025102910593259700_c40","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1126\/science.aaa4967","article-title":"Adoptive cell transfer as personalized immunotherapy for human cancer","volume":"348","year":"2015","journal-title":"Science"},{"issue":"6","key":"2025102910593259700_c41","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2174\/1381612003400597","article-title":"Cytokine therapy for cancer","volume":"6","year":"2000","journal-title":"Curr. Pharm. Des."},{"issue":"4","key":"2025102910593259700_c42","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","article-title":"Harnessing cytokines and chemokines for cancer therapy","volume":"19","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2025102910593259700_c43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/387023","article-title":"Chitin, chitosan, and glycated chitosan regulate immune responses: The novel adjuvants for cancer vaccine","volume":"2013","journal-title":"J. Immunol. Res."},{"issue":"8","key":"2025102910593259700_c44","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1080\/21645515.2017.1321725","article-title":"Use of adjuvants for immunotherapy","volume":"13","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"issue":"5","key":"2025102910593259700_c45","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.3390\/curroncol29050247","article-title":"Immune checkpoint inhibitors in cancer therapy","volume":"29","year":"2022","journal-title":"Curr. Oncol."},{"key":"2025102910593259700_c46","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.trsl.2021.04.008","article-title":"Development of oncolytic viruses for cancer therapy","volume":"237","year":"2021","journal-title":"Transl. Res."},{"issue":"10","key":"2025102910593259700_c47","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1080\/21645515.2020.1723363","article-title":"Recent advances of oncolytic virus in cancer therapy","volume":"16","year":"2020","journal-title":"Hum. Vaccines Immunother."},{"issue":"2","key":"2025102910593259700_c48","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/pcmedi\/pby011","article-title":"Recent updates on cancer immunotherapy","volume":"1","year":"2018","journal-title":"Precis. Clin. Med."},{"issue":"16","key":"2025102910593259700_c49","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1002\/cncr.24429","article-title":"Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer","volume":"115","year":"2009","journal-title":"Cancer"},{"key":"2025102910593259700_c50","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2147\/BTT.S252568","article-title":"How can we engineer CAR T cells to overcome resistance?","volume":"15","year":"2021","journal-title":"Biologics"},{"issue":"15","key":"2025102910593259700_c51","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.3390\/cancers14153575","article-title":"Immune checkpoint inhibitors in cancer therapy\u2014How to overcome drug resistance?","volume":"14","year":"2022","journal-title":"Cancers"},{"key":"2025102910593259700_c52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12248-021-00574-0","article-title":"Cancer immunotherapy update: FDA-approved checkpoint inhibitors and companion diagnostics","volume":"23","year":"2021","journal-title":"AAPS J."},{"issue":"11","key":"2025102910593259700_c53","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1080\/21645515.2016.1199310","article-title":"Pembrolizumab (keytruda)","volume":"12","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"issue":"20","key":"2025102910593259700_c54","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1056\/NEJMoa2112435","article-title":"Pembrolizumab for persistent, recurrent, or metastatic cervical cancer","volume":"385","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"2025102910593259700_c55","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1358\/dot.2014.50.12.2235103","article-title":"Nivolumab","volume":"50","year":"2014","journal-title":"Drugs Today"},{"issue":"3","key":"2025102910593259700_c56","doi-asserted-by":"publisher","first-page":"410","DOI":"10.7150\/jca.17144","article-title":"Nivolumab as programmed death-1 (PD-1) inhibitor for targeted immunotherapy in tumor","volume":"8","year":"2017","journal-title":"J. Cancer"},{"issue":"8","key":"2025102910593259700_c57","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"2025102910593259700_c58","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in previously untreated melanoma without BRAF mutation","volume":"372","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"2025102910593259700_c59","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/bs.podrm.2015.12.002","article-title":"Dacarbazine","volume":"41","year":"2016","journal-title":"Profiles Drug Subst. Excip. Relat. Methodol."},{"issue":"4","key":"2025102910593259700_c60","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ccell.2020.03.017","article-title":"Acquired resistance to immune checkpoint inhibitors","volume":"37","year":"2020","journal-title":"Cancer Cell"},{"issue":"1","key":"2025102910593259700_c61","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/bjc.2017.434","article-title":"Mechanisms of resistance to immune checkpoint inhibitors","volume":"118","year":"2018","journal-title":"Br. J. Cancer"},{"key":"2025102910593259700_c62","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","article-title":"Immune checkpoint inhibitors for the treatment of cancer: Clinical impact and mechanisms of response and resistance","volume":"16","year":"2021","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"issue":"5","key":"2025102910593259700_c63","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.3390\/ijms23052847","article-title":"Challenges of the immunotherapy: Perspectives and limitations of the immune checkpoint inhibitor treatment","volume":"23","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"2025102910593259700_c64","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"2025102910593259700_c65","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fphar.2017.00049","article-title":"Current diagnosis and management of immune related adverse events (irAEs) induced by immune checkpoint inhibitor therapy","volume":"8","year":"2017","journal-title":"Front. Pharmacol."},{"key":"2025102910593259700_c66","doi-asserted-by":"publisher","first-page":"100052","DOI":"10.1016\/j.jpap.2021.100052","article-title":"Photophysical properties and therapeutic use of natural photosensitizers","volume":"7","year":"2021","journal-title":"J. Photochem. Photobiol."},{"issue":"3","key":"2025102910593259700_c67","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/php.13206","article-title":"Photodynamic therapy for gastrointestinal cancer","volume":"96","year":"2020","journal-title":"Photochem. Photobiol."},{"issue":"2","key":"2025102910593259700_c68","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00534-009-0109-3","article-title":"Systematic review: Photodynamic therapy for unresectable cholangiocarcinoma","volume":"17","year":"2010","journal-title":"J. Hepato-Biliary-Pancreat. Sci."},{"issue":"1","key":"2025102910593259700_c69","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1089\/clm.1998.16.61","article-title":"Photodynamic therapy (PDT) in the treatment of patients with resistant superficial bladder cancer: A long term experience","volume":"16","year":"1998","journal-title":"J. Clin. Laser Med. Surg."},{"issue":"5","key":"2025102910593259700_c70","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nrc1071","article-title":"Photodynamic therapy for cancer","volume":"3","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"2025102910593259700_c71","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3322\/caac.20114","article-title":"Photodynamic therapy of cancer: An update","volume":"61","year":"2011","journal-title":"CA. Cancer J. Clin."},{"key":"2025102910593259700_c72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.20517\/2394-4722.2018.83","article-title":"Photodynamic therapy in cancer treatment-an update review","volume":"5","year":"2019","journal-title":"Cancer Metastasis Treat."},{"issue":"14","key":"2025102910593259700_c73","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.3390\/cancers13143484","article-title":"Light technology for efficient and effective photodynamic therapy: A critical review","volume":"13","year":"2021","journal-title":"Cancers"},{"issue":"2","key":"2025102910593259700_c74","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10103-008-0539-1","article-title":"Photophysics and photochemistry of photodynamic therapy: Fundamental aspects","volume":"24","year":"2009","journal-title":"Lasers Med. Sci."},{"issue":"23","key":"2025102910593259700_c75","doi-asserted-by":"publisher","first-page":"14119","DOI":"10.1021\/acs.jmedchem.0c00047","article-title":"Conjugated photosensitizers for imaging and PDT in cancer research","volume":"63","year":"2020","journal-title":"J. Med. Chem."},{"issue":"3","key":"2025102910593259700_c76","doi-asserted-by":"publisher","first-page":"1700481","DOI":"10.1002\/advs.201700481","article-title":"Enhanced photodynamic cancer treatment by mitochondria-targeting and brominated near-infrared fluorophores","volume":"5","year":"2018","journal-title":"Adv. Sci."},{"issue":"25","key":"2025102910593259700_c77","doi-asserted-by":"publisher","first-page":"9888","DOI":"10.1002\/anie.201916729","article-title":"Aggregation-induced emission: New vistas at the aggregate level","volume":"59","year":"2020","journal-title":"Angew. Chem., Int. Ed."},{"issue":"45","key":"2025102910593259700_c78","doi-asserted-by":"publisher","first-page":"1801350","DOI":"10.1002\/adma.201801350","article-title":"Photosensitizers with aggregation-induced emission: Materials and biomedical applications","volume":"30","year":"2018","journal-title":"Adv. Mater."},{"issue":"3","key":"2025102910593259700_c79","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/biomedicines9030305","article-title":"Advances in nanomaterial-mediated photothermal cancer therapies: Toward clinical applications","volume":"9","year":"2021","journal-title":"Biomedicines"},{"key":"2025102910593259700_c80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pmatsci.2018.07.005","article-title":"Nanomaterials as photothermal therapeutic agents","volume":"99","year":"2019","journal-title":"Prog. Mater. Sci."},{"issue":"7","key":"2025102910593259700_c81","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1021\/nl070610y","article-title":"Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy","volume":"7","year":"2007","journal-title":"Nano Lett."},{"issue":"2","key":"2025102910593259700_c82","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1021\/cr010379n","article-title":"Mechanisms of pulsed laser ablation of biological tissues","volume":"103","year":"2003","journal-title":"Chem. Rev."},{"issue":"11","key":"2025102910593259700_c83","doi-asserted-by":"publisher","first-page":"6891","DOI":"10.1021\/acs.chemrev.3c00159","article-title":"Photothermal nanomaterials: A powerful light-to-heat converter","volume":"123","year":"2023","journal-title":"Chem. Rev."},{"issue":"19","key":"2025102910593259700_c84","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1002\/smll.201100669","article-title":"Mitochondria-targeting single-walled carbon nanotubes for cancer photothermal therapy","volume":"7","year":"2011","journal-title":"Small"},{"issue":"15","key":"2025102910593259700_c85","first-page":"4295","article-title":"Effect of different components of laser immunotherapy in treatment of metastatic tumors in rats","volume":"62","year":"2002","journal-title":"Cancer Res."},{"issue":"2","key":"2025102910593259700_c86","doi-asserted-by":"publisher","first-page":"1602225","DOI":"10.1002\/smll.201602225","article-title":"Graphene quantum dots-capped magnetic mesoporous silica nanoparticles as a multifunctional platform for controlled drug delivery, magnetic hyperthermia, and photothermal therapy","volume":"13","year":"2017","journal-title":"Small"},{"key":"2025102910593259700_c87","doi-asserted-by":"publisher","first-page":"120421","DOI":"10.1016\/j.biomaterials.2020.120421","article-title":"Photo-activated chemo-immunotherapy for metastatic cancer using a synergistic graphene nanosystem","volume":"265","year":"2021","journal-title":"Biomaterials"},{"key":"2025102910593259700_c88","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1039\/c0pp00306a","article-title":"Preliminary safety and efficacy results of laser immunotherapy for the treatment of metastatic breast cancer patients","volume":"10","year":"2011","journal-title":"Photochem. Photobiol. Sci."},{"issue":"2","key":"2025102910593259700_c89","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1021\/acsabm.0c01397","article-title":"Immune modulator and low-temperature PTT-induced synergistic immunotherapy for cancer treatment","volume":"4","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"issue":"48","key":"2025102910593259700_c90","doi-asserted-by":"publisher","first-page":"8154","DOI":"10.1002\/adma.201402996","article-title":"Immunological responses triggered by photothermal therapy with carbon nanotubes in combination with anti-CTLA-4 therapy to inhibit cancer metastasis","volume":"26","year":"2014","journal-title":"Adv. Mater."},{"issue":"24","key":"2025102910593259700_c91","doi-asserted-by":"publisher","first-page":"20342","DOI":"10.1021\/acsami.8b05876","article-title":"Photothermal-activatable Fe3O4 superparticle nanodrug carriers with PD-L1 immune checkpoint blockade for anti-metastatic cancer immunotherapy","volume":"10","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"6","key":"2025102910593259700_c92","first-page":"1180","article-title":"Photochemical internalization: A novel technology for delivery of macromolecules into cytosol","volume":"59","year":"1999","journal-title":"Cancer Res."},{"issue":"2","key":"2025102910593259700_c93","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3390\/jcm9020528","article-title":"Photochemical internalization for intracellular drug delivery. From basic mechanisms to clinical research","volume":"9","year":"2020","journal-title":"J. Clin. Med."},{"issue":"2","key":"2025102910593259700_c94","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jphotobiol.2009.04.012","article-title":"Photochemical internalization (PCI) in cancer therapy: From bench towards bedside medicine","volume":"96","year":"2009","journal-title":"J. Photochem. Photobiol. B"},{"issue":"2","key":"2025102910593259700_c95","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1089\/nat.2012.0403","article-title":"Evaluation of biodegradable peptide carriers for light-directed targeting","volume":"23","year":"2013","journal-title":"Nucl. Acid Ther."},{"key":"2025102910593259700_c96","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1039\/c1pp05128h","article-title":"Disulfonated tetraphenyl chlorin (TPCS 2a), a novel photosensitizer developed for clinical utilization of photochemical internalization","volume":"10","year":"2011","journal-title":"Photochem. Photobiol. Sci."},{"issue":"1","key":"2025102910593259700_c97","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1021\/acsami.7b15896","article-title":"Efficient gene delivery mediated by a helical polypeptide: Controlling the membrane activity via multivalency and light-assisted photochemical internalization (PCI)","volume":"10","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"2025102910593259700_c98","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11060-014-1410-9","article-title":"Increased sensitivity of glioma cells to 5-fluorocytosine following photo-chemical internalization enhanced nonviral transfection of the cytosine deaminase suicide gene","volume":"118","year":"2014","journal-title":"J. Neurooncol."},{"issue":"2","key":"2025102910593259700_c99","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/php.13219","article-title":"Light sources and dosimetry techniques for photodynamic therapy","volume":"96","year":"2020","journal-title":"Photochem. Photobiol."},{"issue":"4","key":"2025102910593259700_c100","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrc.2016.25","article-title":"Targeting metastasis","volume":"16","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"22","key":"2025102910593259700_c101","doi-asserted-by":"publisher","first-page":"7595","DOI":"10.1021\/jacs.7b02396","article-title":"Overcoming the limits of hypoxia in photodynamic therapy: A carbonic anhydrase IX-targeted approach","volume":"139","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"2025102910593259700_c102","doi-asserted-by":"publisher","first-page":"110391","DOI":"10.1016\/j.matdes.2022.110391","article-title":"Innovative strategies to boost photothermal therapy at mild temperature mediated by functional nanomaterials","volume":"214","year":"2022","journal-title":"Mater. Des."},{"issue":"17","key":"2025102910593259700_c103","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1002\/adhm.201600121","article-title":"Oxygen nanocarrier for combined cancer therapy: Oxygen-boosted ATP-responsive chemotherapy with amplified ROS lethality","volume":"5","year":"2016","journal-title":"Adv. Healthcare Mater."},{"issue":"1","key":"2025102910593259700_c104","doi-asserted-by":"publisher","first-page":"434","DOI":"10.7150\/thno.67300","article-title":"Recent advances in nanomedicines for photodynamic therapy (PDT)-driven cancer immunotherapy","volume":"12","year":"2022","journal-title":"Theranostics"},{"issue":"23","key":"2025102910593259700_c105","doi-asserted-by":"publisher","first-page":"6867","DOI":"10.7150\/thno.37586","article-title":"A tumor microenvironment responsive biodegradable CaCO3\/MnO2- based nanoplatform for the enhanced photodynamic therapy and improved PD-L1 immunotherapy","volume":"9","year":"2019","journal-title":"Theranostics"},{"issue":"2","key":"2025102910593259700_c106","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1021\/acsami.7b14451","article-title":"Photoelectron transfer at ZnTPyP self-assembly\/TiO2 interfaces for enhanced two-photon photodynamic therapy","volume":"10","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"6","key":"2025102910593259700_c107","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s13233-018-6067-3","article-title":"Functional graphene oxide-based nanosheets for photothermal therapy","volume":"26","year":"2018","journal-title":"Macromol. Res."},{"issue":"1","key":"2025102910593259700_c108","doi-asserted-by":"publisher","first-page":"018003","DOI":"10.1117\/1.JBO.17.1.018003","article-title":"Magnetic-field-assisted photothermal therapy of cancer cells using Fe-doped carbon nanoparticles","volume":"17","year":"2012","journal-title":"J. Biomed. Opt."},{"issue":"1","key":"2025102910593259700_c109","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.2147\/IJN.S46054","article-title":"Accelerated killing of cancer cells using a multifunctional single-walled carbon nanotube-based system for targeted drug delivery in combination with photothermal therapy","volume":"8","year":"2013","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"2025102910593259700_c110","doi-asserted-by":"publisher","first-page":"021009","DOI":"10.1117\/1.3078803","article-title":"Cancer photothermal therapy in the near-infrared region by using single-walled carbon nanotubes","volume":"14","year":"2009","journal-title":"J. Biomed. Opt."},{"issue":"18","key":"2025102910593259700_c111","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.1158\/0008-5472.CAN-12-1003","article-title":"Effective photothermal chemotherapy using doxorubicin-loaded gold nanospheres that target EphB4 receptors in tumors","volume":"72","year":"2012","journal-title":"Cancer Res."},{"issue":"16","key":"2025102910593259700_c112","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.7150\/thno.26291","article-title":"Therapeutic mesopore construction on 2D Nb2C MXenes for targeted and enhanced chemo-photothermal cancer therapy in NIR-II biowindow","volume":"8","year":"2018","journal-title":"Theranostics"},{"issue":"1","key":"2025102910593259700_c113","doi-asserted-by":"publisher","first-page":"3623","DOI":"10.1038\/ncomms4623","article-title":"Harnessing photochemical internalization with dual degradable nanoparticles for combinatorial photo\u2013chemotherapy","volume":"5","year":"2014","journal-title":"Nat. Commun."},{"key":"2025102910593259700_c114","doi-asserted-by":"publisher","first-page":"120579","DOI":"10.1016\/j.carbpol.2023.120579","article-title":"Small anticancer drug release by light: Photochemical internalization of porphyrin-\u03b2-cyclodextrin nanoparticles","volume":"306","year":"2023","journal-title":"Carbohydr. Polym."},{"issue":"9","key":"2025102910593259700_c115","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.3390\/molecules25092193","article-title":"Therapeutic nanoparticles and their targeted delivery applications","volume":"25","year":"2020","journal-title":"Molecules"},{"issue":"5","key":"2025102910593259700_c116","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.7150\/thno.53056","article-title":"Cancer photo-immunotherapy: From bench to bedside","volume":"11","year":"2021","journal-title":"Theranostics"},{"issue":"6","key":"2025102910593259700_c117","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1158\/1078-0432.CCR-15-0515","article-title":"Combination of photodynamic therapy and specific immunotherapy efficiently eradicates established tumors","volume":"22","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"2025102910593259700_c118","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1158\/1078-0432.CCR-05-1986","article-title":"Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy","volume":"12","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"2025102910593259700_c119","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.3390\/pharmaceutics15041295","article-title":"Adoptive transfer of photosensitizer-loaded cytotoxic T cells for combinational photodynamic therapy and cancer immuno-therapy","volume":"15","year":"2023","journal-title":"Pharmaceutics"},{"issue":"4","key":"2025102910593259700_c120","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.7150\/thno.38515","article-title":"Neutrophil infiltration and whole-cell vaccine elicited by N-dihydrogalactochitosan combined with NIR phototherapy to enhance antitumor immune response and T cell immune memory","volume":"10","year":"2020","journal-title":"Theranostics"},{"issue":"7","key":"2025102910593259700_c121","doi-asserted-by":"publisher","first-page":"e937","DOI":"10.1002\/ctm2.937","article-title":"Single-cell RNA sequencing reveals localized tumour ablation and intratumoural immunostimulant delivery potentiate T cell mediated tumour killing","volume":"12","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"21","key":"2025102910593259700_c122","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.1158\/1078-0432.CCR-18-1126","article-title":"Local phototherapy synergizes with immunoadjuvant for treatment of pancreatic cancer through induced immunogenic tumor vaccine","volume":"24","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"2025102910593259700_c123","doi-asserted-by":"publisher","first-page":"2100093","DOI":"10.1002\/adtp.202100093","article-title":"Photothermal therapy combined with neoantigen cancer vaccination for effective immunotherapy against large established tumors and distant metastasis","volume":"4","year":"2021","journal-title":"Adv. Ther."},{"issue":"36","key":"2025102910593259700_c124","doi-asserted-by":"publisher","first-page":"8261","DOI":"10.1039\/D0TB01453B","article-title":"Biodegradable pH-responsive amorphous calcium carbonate nanoparticles as immunoadjuvants for multimodal imaging and enhanced photoimmunotherapy","volume":"8","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"2025102910593259700_c125","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3389\/fimmu.2018.00650","article-title":"Photochemical internalization of peptide antigens provides a novel strategy to realize therapeutic cancer vaccination","volume":"9","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"2025102910593259700_c126","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1039\/C7BM01082F","article-title":"Photosensitizer-induced self-assembly of antigens as nanovaccines for cancer immunotherapy","volume":"6","year":"2018","journal-title":"Biomater. Sci."},{"issue":"12","key":"2025102910593259700_c127","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1515\/nanoph-2021-0171","article-title":"Nano-ablative immunotherapy for cancer treatment","volume":"10","year":"2021","journal-title":"Nanophotonics"},{"issue":"2","key":"2025102910593259700_c128","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1021\/acsnano.7b09112","article-title":"Enhanced immunotherapy based on photodynamic therapy for both primary and lung metastasis tumor eradication","volume":"12","year":"2018","journal-title":"ACS Nano"},{"issue":"1","key":"2025102910593259700_c129","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s43556-022-00086-z","article-title":"Combinatorial therapeutic approaches of photodynamic therapy and immune checkpoint blockade for colon cancer treatment","volume":"3","year":"2022","journal-title":"Mol. Biomed."},{"issue":"21","key":"2025102910593259700_c130","doi-asserted-by":"publisher","first-page":"2200999","DOI":"10.1002\/advs.202200999","article-title":"Time rules the efficacy of immune checkpoint inhibitors in photodynamic therapy","volume":"9","year":"2022","journal-title":"Adv. Sci."},{"issue":"5","key":"2025102910593259700_c131","doi-asserted-by":"publisher","first-page":"627","DOI":"10.7150\/thno.14792","article-title":"Enhanced anti-tumor efficacy through a combination of integrin \u03b1v\u03b26-targeted photodynamic therapy and immune checkpoint inhibition","volume":"6","year":"2016","journal-title":"Theranostics"},{"issue":"1","key":"2025102910593259700_c132","doi-asserted-by":"publisher","first-page":"8606","DOI":"10.1038\/s41598-017-09116-1","article-title":"Synergistic immuno photothermal nanotherapy (SYMPHONY) for the treatment of unresectable and metastatic cancers","volume":"7","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"2025102910593259700_c133","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S1470-2045(02)00818-5","article-title":"Hyperthermia in combined treatment of cancer","volume":"3","year":"2002","journal-title":"Lancet Oncol."},{"issue":"6","key":"2025102910593259700_c134","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3109\/02656736.2012.677933","article-title":"Old and new facts about hyperthermia-induced modulations of the immune system","volume":"28","year":"2012","journal-title":"Int. J. Hyperthermia"},{"issue":"1","key":"2025102910593259700_c135","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S1040-8428(01)00179-2","article-title":"The cellular and molecular basis of hyperthermia","volume":"43","year":"2002","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"issue":"10","key":"2025102910593259700_c136","doi-asserted-by":"publisher","first-page":"1802157","DOI":"10.1002\/advs.201802157","article-title":"Nir-triggered phototherapy and immunotherapy via an antigen-capturing nanoplatform for metastatic cancer treatment","volume":"6","year":"2019","journal-title":"Adv. Sci."},{"key":"2025102910593259700_c137","doi-asserted-by":"publisher","first-page":"1278000","DOI":"10.3389\/fimmu.2023.1278000","article-title":"Light-enhanced VEGF121\/rGel induce immunogenic cell death and increase the antitumor activity of \u03b1CTLA4 treatment","volume":"14","year":"2023","journal-title":"Front. Immunol."},{"issue":"12","key":"2025102910593259700_c138","doi-asserted-by":"publisher","first-page":"7866","DOI":"10.1073\/pnas.122157899","article-title":"In vitro and in vivo studies of a VEGF121\/rGelonin chimeric fusion toxin targeting the neovasculature of solid tumors","volume":"99","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2025102910593259700_c139","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jconrel.2018.09.005","article-title":"Light-enhanced VEGF121\/rGel: A tumor targeted modality with vascular and immune-mediated efficacy","volume":"288","year":"2018","journal-title":"J. Controlled Release"},{"key":"2025102910593259700_c140","article-title":"Cancer survival by stage at diagnosis for England (experimental statistics): Adults diagnosed 2012, 2013 and 2014 and followed up to 2015","year":"2016"},{"issue":"2","key":"2025102910593259700_c141","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1021\/cr068105t","article-title":"Optical biosensors","volume":"108","year":"2008","journal-title":"Chem. Rev."},{"issue":"1","key":"2025102910593259700_c142","first-page":"50","article-title":"Raman spectroscopy, review","volume":"6","year":"2016","journal-title":"Int. J. Eng. Tech. Res."},{"key":"2025102910593259700_c143","doi-asserted-by":"publisher","year":"2008","journal-title":"Encyclopedia of Life Sciences (ELS)","DOI":"10.1002\/9780470015902.a0003082"},{"issue":"6","key":"2025102910593259700_c144","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.3390\/s21062230","article-title":"A miniature bio-photonics companion diagnostics platform for reliable cancer treatment monitoring in blood fluids","volume":"21","year":"2021","journal-title":"Sensors"},{"issue":"5","key":"2025102910593259700_c145","doi-asserted-by":"publisher","first-page":"10481","DOI":"10.3390\/s150510481","article-title":"Surface plasmon resonance: a versatile technique for biosensor applications","volume":"15","year":"2015","journal-title":"Sensors"},{"issue":"5","key":"2025102910593259700_c146","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s11468-021-01425-6","article-title":"Cancer detection with surface plasmon resonance-based photonic crystal fiber biosensor","volume":"16","year":"2021","journal-title":"Plasmonics"},{"issue":"1","key":"2025102910593259700_c147","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1038\/s41598-022-07723-1","article-title":"Predictions of cervical cancer identification by photonic method combined with machine learning","volume":"12","year":"2022","journal-title":"Sci. Rep."},{"issue":"38","key":"2025102910593259700_c148","doi-asserted-by":"publisher","first-page":"1802061","DOI":"10.1002\/adma.201802061","article-title":"Two-dimensional antimonene-based photonic nanomedicine for cancer theranostics","volume":"30","year":"2018","journal-title":"Adv. Mater."},{"key":"2025102910593259700_c149","doi-asserted-by":"publisher","first-page":"133273","DOI":"10.1016\/j.cej.2021.133273","article-title":"Oxygen-deficient tungsten oxide perovskite nanosheets-based photonic nanomedicine for cancer theranostics","volume":"431","year":"2022","journal-title":"Chem. Eng. J."},{"issue":"2","key":"2025102910593259700_c150","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1039\/C8NH00299A","article-title":"Photonic cancer nanomedicine using the near infrared-II biowindow enabled by biocompatible titanium nitride nanoplatforms","volume":"4","year":"2019","journal-title":"Nanoscale Horiz."}],"container-title":["APL Bioengineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.aip.org\/aip\/apb\/article-pdf\/doi\/10.1063\/5.0252574\/20779634\/041503_1_5.0252574.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.aip.org\/aip\/apb\/article-pdf\/doi\/10.1063\/5.0252574\/20779634\/041503_1_5.0252574.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:59:41Z","timestamp":1761749981000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.aip.org\/apb\/article\/9\/4\/041503\/3370000\/Synergy-between-photonics-and-biological"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":150,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1063\/5.0252574","relation":{},"ISSN":["2473-2877"],"issn-type":[{"value":"2473-2877","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12,1]]},"published":{"date-parts":[[2025,10,29]]},"article-number":"041503"}}